omeprazole has been researched along with Antibiotic-Associated Colitis in 7 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 38-year-old Caucasian man with mild hypertension and no other significant medical history developed profound erectile dysfunction within 2 days of initiating over-the-counter omeprazole therapy, with erectile function rapidly normalizing following discontinuation of the drug." | 8.02 | Abrupt-onset, profound erectile dysfunction in a healthy young man after initiating over-the-counter omeprazole: a case report. ( Perry, TW, 2021) |
| "A 38-year-old Caucasian man with mild hypertension and no other significant medical history developed profound erectile dysfunction within 2 days of initiating over-the-counter omeprazole therapy, with erectile function rapidly normalizing following discontinuation of the drug." | 4.02 | Abrupt-onset, profound erectile dysfunction in a healthy young man after initiating over-the-counter omeprazole: a case report. ( Perry, TW, 2021) |
| "We describe a 54-year-old man with Helicobacter pylori (+) duodenal ulcer who developed Clostridium difficile associated colitis, 5 days after commencing a 'triple' regimen consisting of omeprazole 20 mg b." | 3.70 | Clostridium difficile colitis associated with a 'triple' regimen, containing clarithromycin and metronidazole, to eradicate Helicobacter pylori. ( Archimandritis, A; Katsorida, M; Souyioultzis, S; Tzivras, M, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Perry, TW | 1 |
| Freedberg, DE | 1 |
| Toussaint, NC | 1 |
| Chen, SP | 1 |
| Ratner, AJ | 1 |
| Whittier, S | 1 |
| Wang, TC | 1 |
| Wang, HH | 1 |
| Abrams, JA | 1 |
| Rai, R | 1 |
| Rai, S | 1 |
| Kubo, N | 1 |
| Kochi, S | 1 |
| Ariyama, I | 1 |
| Murata, M | 1 |
| Furusyo, N | 1 |
| Hayashi, J | 1 |
| Schweigart, U | 1 |
| Franck, H | 1 |
| Schepp, W | 1 |
| Lehn, N | 1 |
| Becker, K | 1 |
| Classen, M | 1 |
| Archimandritis, A | 1 |
| Souyioultzis, S | 1 |
| Katsorida, M | 1 |
| Tzivras, M | 1 |
| Lau, CF | 1 |
| Hui, PK | 1 |
| Fung, TT | 1 |
| Tung, SY | 1 |
| Wong, AM | 1 |
| Loo, CK | 1 |
| Lam, KM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effects of Gastric Acid Suppression on the Colonic Microbiome[NCT01901276] | Phase 4 | 12 participants (Actual) | Interventional | 2013-08-31 | Completed | ||
| Factors Influencing the Human Gut Microbiome Profile in Multi-ethnic Groups of the Singapore Community (FAMES)[NCT02893709] | 36 participants (Actual) | Interventional | 2015-06-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for omeprazole and Antibiotic-Associated Colitis
| Article | Year |
|---|---|
Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial.
Topics: Bacteria; Clostridioides difficile; Cross-Over Studies; Drug Administration Schedule; Enterocolitis, | 2015 |
Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial.
Topics: Bacteria; Clostridioides difficile; Cross-Over Studies; Drug Administration Schedule; Enterocolitis, | 2015 |
Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial.
Topics: Bacteria; Clostridioides difficile; Cross-Over Studies; Drug Administration Schedule; Enterocolitis, | 2015 |
Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial.
Topics: Bacteria; Clostridioides difficile; Cross-Over Studies; Drug Administration Schedule; Enterocolitis, | 2015 |
6 other studies available for omeprazole and Antibiotic-Associated Colitis
| Article | Year |
|---|---|
Abrupt-onset, profound erectile dysfunction in a healthy young man after initiating over-the-counter omeprazole: a case report.
Topics: Adult; Aged; Enterocolitis, Pseudomembranous; Erectile Dysfunction; Humans; Male; Omeprazole; Proton | 2021 |
Pseudomembranous colitis requiring surgical intervention following triple therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Clarithromycin; Drug Therapy, Combination; Enterocol | 2002 |
[Pseudomembranous colitis after Helicobacter pylori eradication therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Ag | 2006 |
[Toxic megacolon after Helicobacter pylori eradication therapy].
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Colon; Diagnosis, Differential; Drug Therapy, Combination; Ent | 1997 |
Clostridium difficile colitis associated with a 'triple' regimen, containing clarithromycin and metronidazole, to eradicate Helicobacter pylori.
Topics: Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Enterocolitis, Pseudom | 1998 |
Pseudomembranous colitis without diarrhoea following Helicobacter pylori eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents | 2001 |